AzTrials
AzTrials

Physical Functional ImpairmentNCT07104435

Community Recreation to Enhance Function in Aging

A study testing Artmaking and exergaming in people with Physical Functional Impairment and Cognitive Impairment, run by State University of New York at Buffalo at 1 site in United States.

Active, not recruiting

Under way, not looking for participants. Everyone needed has enrolled. The study is still running.

Official record
Search all trials

Trial summary

This aim of this study is to examine the therapeutic impacts of a group-based recreational program that delivers guided visual artmaking and dual-task exergaming, to older adults. Read more about this study

Who is it for?
Ages 60 years and olderHealthy volunteers can take part
What is being tested?
Artmaking and exergaming
Could I receive a placebo?
No, everyone receives an active treatment
How many people
80 participants
Where
1 siteUnited States
Study dates
12 Sep 2025to 15 Jul 2027
Phase
Interventional
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 60 years and older
  • All sexes
  • Healthy volunteers accepted
  • Adult, Older adult

Who may be able to join

  • Have no more than MCI (Montreal Cognitive Assessment score ≥ 24 points)
  • Have no contraindications to exercise guided by the American College of Sports Medicine (ACSM)
  • Fluent in English

Who cannot join

  • Have a condition that would prevent safe participation in the exercise, as determined by the Physical Activity Readiness Questionnaire for Older Adults
  • Have severe neurological disease.
  • Have severe psychiatric illness.
  • Have a likelihood of withdrawing from the study due to severe illness or a life expectancy of < 6 mo.
  • Having a lower or upper limb amputation

Trial locations and contacts

1 site in 1 country.

United States1 site
  • University at Buffalo

    Buffalo, New York, 14223

Other trials in United States

About this study

Official title: A Community-Based Recreation Program to Improve Function and Quality of Life in Older Adults

This aim of this study is to examine the therapeutic impacts of a group-based recreational program that delivers guided visual artmaking and dual-task exergaming, to older adults. Outcomes of interest include cognitive function (attention, task-switching, interference inhibition), physical function (balance, walking, lower-limb strength), and dual-task performance. Key implementation outcomes including intervention fidelity, feasibility, and acceptability will be explored to inform design of future community-based intervention programs.

Being tested
Artmaking and exergaming
Medical subject headings
Cognitive Dysfunction

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Artmaking and exergamingOther

    Weekly visual artmaking and exergaming

Study groups in NCT07104435
Study groupRoleWhat they receive
ControlNo interventionNo artmaking, no exergaming
Artmaking and ExergamingExperimentalWeekly group-based visual artmaking and dual-task exergaming
Receives: Other: Artmaking and exergaming

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Change in performance on the Stroop Color-Word Test

    Change in score on the Stroop Color-Word Test

    Measured: From enrollment to study end at 24 weeks

  2. Performance on the Trail Making Test

    Change in score on the Trail Making Test

    Measured: From baseline to study end at 24 weeks

Secondary outcomes (3)
  1. Performance on Four Stage Balance Test

    Change in score on the Four Stage Balance Test

    Measured: From baseline to study end at 24 weeks

  2. Performance on the Six-Minute Walk Test

    Change in score on the Six-Minute Walk Test

    Measured: From baseline to study end at 24 weeks

  3. Dual-Task Ability

    Change in scores on the Timed Up and Go Test: Dual Task

    Measured: From baseline to study end at 24 weeks

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted5 Aug 2025
  2. Study start12 Sep 2025
  3. Primary completion1 Jul 2027 (estimated)
  4. Study completion15 Jul 2027 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Other
Allocation
Randomised
Intervention model
Parallel groups
Masking
Single blind
Who is masked
Outcomes assessor
Enrolment
80 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07104435
Sponsor's protocol ID
1193595
Status last verified
Jun 2026
First submitted
29 Jul 2025
Last updated
2 Jun 2026
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No

Questions about this trial

What is this clinical trial studying?

A study testing Artmaking and exergaming in people with Physical Functional Impairment and Cognitive Impairment, run by State University of New York at Buffalo at 1 site in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 3 inclusion and 5 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: under way, not looking for participants, as of the sponsor's last update on 2 Jun 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Change in performance on the Stroop Color-Word Test (time frame: From enrollment to study end at 24 weeks). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 2 Jun 2026.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in